HTA136 Impact on Scottish Medicines Consortium Reimbursement Decisions When Assessed Under the Orphan Drug Process
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1594
https://www.valueinhealthjournal.com/article/S1098-3015(22)03799-8/fulltext
Title :
HTA136 Impact on Scottish Medicines Consortium Reimbursement Decisions When Assessed Under the Orphan Drug Process
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03799-8&doi=10.1016/j.jval.2022.09.1594
First page :
Section Title :
Open access? :
No
Section Order :
11151